Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Anti-human statin alpha monoclonal antibody, preparation method thereof, immunodetection reagent and application

A monoclonal antibody and inhibin technology, applied in the direction of anti-animal/human immunoglobulin, anti-growth factor immunoglobulin, measuring devices, etc., can solve the problems of high price and high cost of differential diagnosis

Pending Publication Date: 2022-04-05
河南赛诺特生物技术有限公司
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Monoclonal antibody R1 is an imported reagent, which is expensive, which also leads to high cost of differential diagnosis in this field

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Anti-human statin alpha monoclonal antibody, preparation method thereof, immunodetection reagent and application
  • Anti-human statin alpha monoclonal antibody, preparation method thereof, immunodetection reagent and application
  • Anti-human statin alpha monoclonal antibody, preparation method thereof, immunodetection reagent and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] The anti-human inhibin α monoclonal antibody of this embodiment comprises a heavy chain variable region with an amino acid sequence shown in SEQ ID NO:7 and a light chain variable region with an amino acid sequence shown in SEQ ID NO:8. The heavy chain variable region comprises VHCDR1, VHCDR2 and VHCDR3 as shown in SEQ ID NO: 1-3, and the light chain variable region comprises VLCDR1, VLCDR2 and VLCDR3 as shown in SEQ ID NO: 4-6.

[0033] Two. Specific examples of the preparation method of the monoclonal antibody against human inhibin alpha

Embodiment 2

[0035] The preparation method of the anti-human inhibin alpha monoclonal antibody of the present embodiment comprises the following steps:

[0036] (1) Rabbit immunization: add 5 kinds of immunogens (immunogens I, II, III, IV, and V are MSH6, Inhibin-α, MLH1, CK19, and PMS2) and immune partners (CSF2 protein; enhance immune effect) into water-soluble In the adjuvant, the immune reagent was obtained, and the concentration of the immune partner in the immune reagent was controlled to be 50 μg / mL, and the immune dose of the five immunogens was 100 μg / monkey. Then, New Zealand white rabbits were immunized with immune reagents, and after the immune effect was evaluated to meet expectations, the rabbits were subjected to immunogen shock immunization, so as to mobilize the rapid activation of B lymphocytes targeting the target immunogen in the rabbit body.

[0037] CSF2 protein can be prepared by a method comprising the following steps:

[0038] 1) First, by consulting the Uniprot d...

Embodiment 3

[0058] The immunological detection reagent of this embodiment is an immunohistochemical detection reagent, which is the monoclonal antibody working solution of Example 1, the concentration of the monoclonal antibody is 0.1 μg / mL, and the solvent is TBS buffer solution, which contains a concentration of 10 mg / mL BSA (bovine serum albumin) and preservatives Proclin-300 and Proclin-950 were added in a ratio of 1:1000 (V / V).

[0059] 4. Specific examples of the application of monoclonal antibodies in immunohistochemistry

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Antibody concentrationaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of monoclonal antibodies, and particularly relates to an anti-human statin alpha (Inhistatin-alpha) monoclonal antibody as well as a preparation method, an immunodetection reagent and application thereof. The monoclonal antibody comprises a VHCDR1, a VHCDR2 and a VHCDR3 of which the amino acid sequences are shown as SEQ ID NO: 1-3, and a VLCDR1, a VLCDR2 and a VLCDR3 of which the amino acid sequences are shown as SEQ ID NO: 4-6. The anti-human statin alpha monoclonal antibody provided by the invention can accurately identify Inhibin-alpha protein expressed in paraffin tissue and frozen tissue, and compared with an imported reagent R1, the monoclonal antibody has the advantages of consistent specific evaluation result, low antibody use concentration and stronger dyeing effect, and can be used for immunodetection analysis. The monoclonal antibody has important significance for realizing localization of the monoclonal antibody and reducing reagent cost.

Description

technical field [0001] The invention belongs to the field of monoclonal antibodies, and in particular relates to an anti-human inhibin-α (Inhibin-α) monoclonal antibody, a preparation method thereof, an immunodetection reagent and applications thereof. Background technique [0002] Inhibin (INH) is an important regulator of activin (ACT) function. The structure of inhibin is related to activin, and both belong to the transforming growth factor β (TGF-β) superfamily member. Inhibin is a heterodimeric glycoprotein INHA or INHB formed by two subunits of α and β (βA or βB) through disulfide bonds, with a relative molecular weight of 32KD. The respective bases of these three subunits α, βA, and βB The base sequences were located on chromosome 2 (α subunit and βB subunit) and chromosome 7 (βA subunit). Inhibin acts against activin by competing for binding to activin type II receptors, a process that requires inhibin co-receptor-β-glycans to increase inhibin affinity. [0003] In...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K16/22C12N15/85G01N33/577G01N33/574
Inventor 翟晋豫王远利许鹏程王晓亚李艳娟吴夏梦常秋霜秦志洁齐华李三华
Owner 河南赛诺特生物技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com